SECTM1 and leukemia: Systemic leukemia development, as evaluated by bioluminescence, was detected on day 12 in the control and CD19 CAR-T-cell-treated groups, whereas no systemic leukemia was detected in K12 CAR-T-cell-treated mice (Figures 4B and 4C).